Baxter International (BAX) Revenue (2009 - 2026)

Baxter International (BAX) has 18 years of Revenue data on file, last reported at $2.7 billion in Q1 2026.

• On a quarterly basis, Revenue rose 2.9% year-over-year to $2.7 billion in Q1 2026; TTM through Mar 2026 was $10.8 billion, a 0.06% change from a year earlier, with the FY2025 full-year figure at $11.2 billion, up 5.72% from the prior year.
• Revenue for Q1 2026 stood at $2.7 billion, up from $2.6 billion in the prior quarter.
• Over the last five years, Revenue for BAX reached as high as $3.7 billion in Q4 2022 and fell as low as $2.4 billion in Q1 2023.
• Historically, Revenue has averaged $2.9 billion across 5 years, with a median of $2.7 billion in 2024.
• Across the five-year window, Revenue jumped 30.22% in 2022 and sank 31.39% in 2023, its largest moves.
• Year by year, Revenue stood at $3.7 billion in 2022, then decreased by 27.13% to $2.7 billion in 2023, then rose by 0.88% to $2.8 billion in 2024, then slipped by 4.65% to $2.6 billion in 2025, then advanced by 2.9% to $2.7 billion in 2026.
• Per Business Quant data, the three most recent Revenue figures were $2.7 billion in Q1 2026, $2.6 billion in Q1 2025, and $2.8 billion in Q4 2024.